Halozyme Therapeutics | Salg Og Administrasjonskostnader

Selling And Administration Expenses Endring Dato
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amarin USD 45.46M 5.5M 2023-09
Amgen USD 1.76B 424M 2023-12
Baxter International USD 832M 47M 2023-12
Cytokinetics USD 44.11M 4M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
MannKind USD 20.54M 3.44M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
United Therapeutics USD 128.6M 1000K 2023-12



Halozyme Therapeutics Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.